loadpatents
name:-0.039685010910034
name:-0.019668102264404
name:-0.017372846603394
CROWE, Jr.; JAMES E. Patent Filings

CROWE, Jr.; JAMES E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for CROWE, Jr.; JAMES E..The latest application filed is for "human monoclonal antibodies to enterovirus d68".

Company Profile
14.20.34
  • CROWE, Jr.; JAMES E. - Nashville TN
  • Crowe, JR.; James E - Nashville TN
  • Crowe, Jr.; James E. - Brentwood TN
  • Crowe, Jr.; James E. - Chevy Chase MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Human Monoclonal Antibodies To Enterovirus D68
App 20220289828 - CROWE, Jr.; JAMES E. ;   et al.
2022-09-15
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
App 20220281958 - CROWE, JR.; James E. ;   et al.
2022-09-08
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Grant 11,345,741 - Crowe, Jr. , et al. May 31, 2
2022-05-31
Antibody-mediated neutralization of chikungunya virus
Grant 11,345,743 - Crowe, Jr. , et al. May 31, 2
2022-05-31
Human Monoclonal Antibodies To Staphylococcal Aureus Isd Proteins And Uses Thereof
App 20220080036 - Crowe, Jr.; James E. ;   et al.
2022-03-17
Pan-ebolavirus Neutralizing Human Antibodies And Methods Of Use Therefor
App 20210403538 - CROWE, Jr.; James E. ;   et al.
2021-12-30
Human Zika Virus Antibodies And Methods Of Use Therefor
App 20210347864 - CROWE, Jr.; James E.
2021-11-11
Human Monoclonal Antibodies That Neutralize Pandemic Gii.4 Noroviruses
App 20210324050 - Crowe, Jr.; James E. ;   et al.
2021-10-21
Antibody-mediated Neutralization Of Marburg Virus
App 20210324051 - CROWE, Jr.; James E. ;   et al.
2021-10-21
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
App 20210300999 - CROWE, JR.; James E. ;   et al.
2021-09-30
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
App 20210277092 - Crowe, JR.; James E. ;   et al.
2021-09-09
Human Monoclonal Antibodies To A New Universal Influenza A Hemagglutinin Head Domain Epitope
App 20210252150 - Crowe, Jr.; James E.
2021-08-19
Antibody-mediated neutralization of Marburg virus
Grant 11,084,869 - Crowe, Jr. , et al. August 10, 2
2021-08-10
Antibody-mediated neutralization of ebolaviruses
Grant 11,054,423 - Crowe, Jr. , et al. July 6, 2
2021-07-06
Human Zika virus antibodies and methods of use therefor
Grant 11,021,533 - Crowe, Jr. June 1, 2
2021-06-01
Human West Nile Virus Antibodies And Methods Of Use Therefor
App 20210115115 - Crowe, Jr.; James E.
2021-04-22
Human monoclonal antibodies to Staphylococcus aureus lukab toxin
Grant 10,981,979 - Crowe, Jr. , et al. April 20, 2
2021-04-20
Antibody-mediated Nutralization Of Chikungunya Virus
App 20210009662 - Crowe, JR.; James E
2021-01-14
Human Japanese Encephalitis Virus Antibodies And Methods Of Use Therefor
App 20200390879 - Crowe, Jr.; James E.
2020-12-17
Polynucleotides Encoding Anti-chikungunya Virus Antibodies
App 20200369748 - Himansu; Sunny ;   et al.
2020-11-26
Antibody-mediated neutralization of Chikungunya virus
Grant 10,787,503 - Crowe, Jr. , et al. September 29, 2
2020-09-29
Antibody-mediated Neutralization Of Chikungunya Virus
App 20200277359 - CROWE, Jr.; James E. ;   et al.
2020-09-03
Antibody-mediated Neutralization Of Ebola Viruses
App 20200200749 - CROWE, Jr.; James E. ;   et al.
2020-06-25
Hepatitis C Virus Gene Sequences And Methods Of Use Therefor
App 20200188504 - CROWE, JR.; James E. ;   et al.
2020-06-18
Antibody-mediated neutralization of Ebola viruses
Grant 10,620,204 - Crowe, Jr. , et al.
2020-04-14
Human Orthopoxvirus Antibodies And Methods Of Use Therefor
App 20200071389 - CROWE, Jr.; James E. ;   et al.
2020-03-05
Antibody-mediated Neutralization Of Marburg Virus
App 20200040066 - CROWE, Jr.; James E. ;   et al.
2020-02-06
Human Monoclonal Antibodies To Staphylococcus Aureus Lukab Toxin
App 20200010536 - CROWE, Jr.; James E. ;   et al.
2020-01-09
Antibodies To Human Respiratory Syncytial Virus Protein F Pre-fusion Conformation And Methods Of Use Therefor
App 20190367586 - Crowe, JR.; James E. ;   et al.
2019-12-05
Human Zika Virus Antibodies And Methods Of Use Therefor
App 20190276520 - CROWE, JR.; James E.
2019-09-12
Chimeric Dengue Virus E Glycoproteins Comprising Mutant Domain I And Domain Ii Hinge Regions
App 20190255168 - de Silva; Aravinda M. ;   et al.
2019-08-22
Human Respiratory Syncytial Virus Antibodies And Methods Of Use Therefor
App 20190240316 - Crowe, Jr.; James E. ;   et al.
2019-08-08
Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions
Grant 10,117,924 - de Silva , et al. November 6, 2
2018-11-06
Antibody-mediated Neutralization Of Ebola Viruses
App 20180180614 - CROWE, JR.; James E. ;   et al.
2018-06-28
Chimeric Dengue Virus E Glycoproteins Comprising Mutant Domain I And Domain Ii Hinge Regions
App 20180125964 - de Silva; Aravinda M. ;   et al.
2018-05-10
Antibody-mediated Neutralization Of Chikungunya Virus
App 20180079802 - CROWE, Jr.; James E. ;   et al.
2018-03-22
Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions
Grant 9,821,050 - De Silva , et al. November 21, 2
2017-11-21
Dendritic Molecular Intracellular Transporters and Methods of Making and Using Same
App 20150315174 - Harth; Eva M. ;   et al.
2015-11-05
Dendritic molecular intracellular transporters and methods of making and using same
Grant 8,969,622 - Harth , et al. March 3, 2
2015-03-03
Neutralizing monoclonal antibodies to respiratory syncytial virus
Grant 8,221,759 - Pilkington , et al. July 17, 2
2012-07-17
Monoclonal Antibodies To Influenza H1n1 Virus Uses Thereof
App 20120100142 - Crowe, JR.; James E. ;   et al.
2012-04-26
Neutralizing Monoclonal Antibodies To Respiratory Syncytial Virus
App 20120087909 - Pilkington; Glenn R. ;   et al.
2012-04-12
Monoclonal antibodies to respiratory syncytial virus and uses therefor
Grant 7,867,497 - Crowe, Jr. January 11, 2
2011-01-11
Virus-Like paramyxovirus particles and vaccines
App 20100040650 - Crowe, JR.; James E. ;   et al.
2010-02-18
Vaccine For Rsv And Mpv
App 20090162395 - Crowe, JR.; James E. ;   et al.
2009-06-25
Neutralizing monoclonal antibodies to respiratory syncytial virus
App 20090110684 - Pilkington; Glenn R. ;   et al.
2009-04-30
Monoclonal Antibodies To Respiratory Syncytial Virus And Uses Therefor
App 20090092609 - Crowe, JR.; James E.
2009-04-09
Neutralizing monoclonal antibodies to respiratory syncytial virus
Grant 7,488,477 - Pilkington , et al. February 10, 2
2009-02-10
Human neutralizing monoclonal antibodies to respiratory syncytial virus
Grant 7,364,737 - Burton , et al. April 29, 2
2008-04-29
Human neutralizing monoclonal antibodies to respiratory syncytial virus
Grant 6,685,942 - Burton , et al. February 3, 2
2004-02-03
Attenuated respiratory syncytial virus vaccine compositions
Grant 5,922,326 - Murphy , et al. July 13, 1
1999-07-13
Attenuated respiratory syncytial virus vaccine compositions
Grant 5,882,651 - Murphy , et al. March 16, 1
1999-03-16
Human neutralizing monoclonal antibodies to respiratory syncytial virus
Grant 5,762,905 - Burton , et al. June 9, 1
1998-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed